Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

All trans retinoic acid in acute promyelocytic leukemia

Abstract

All trans retinoic acid (ATRA) is able to induce complete remission (CR) in almost all patients with acute promyelocytic leukemia (APL) through in vivo differentiation of APL blasts. However, it cannot eliminate the leukemic clone and to be effective must be used in combination with anthracycline-based chemotherapy. Experience accumulated over the last 10 years has clearly shown that the combination of ATRA and chemotherapy gives better survival in newly diagnosed APL than chemotherapy alone because of fewer relapses and a higher CR rate experienced by these patients. It is also strongly suggested that maintenance treatment with ATRA, and possibly in combination with low-dose chemotherapy, can further reduce the incidence of relapse. Overall, more than 90% of patients with newly diagnosed APL can achieve CR and about 75% can be cured by the combination of ATRA and chemotherapy.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy article

Get time limited or full article access on ReadCube.

$32.00

All prices are NET prices.

Abbreviations

APL:

acute promyelocytic leukemia

ATRA:

all trans retinoic acid

References

  • Arnould C, Philippe C, Bourdon V, Gregoire MJ, Berger R, Jonveaux P . 1999 Hum. Mol. Genet. 8: 1741–1749

  • Avvisati G, Mele A, Stazi MA, Vegna ML, Pasquini P, Mandelli F . 1991 Ann. Oncol. 2: 405–408

  • Avvisati G, Ten Cate JW, Mandelli F . 1990 The coagulopathy in APL: DIC? Muszbek L (ed): Hemostasis and Cancer Boca Raton, FL, CRC pp. 91–100

  • Avvisati G . 1999 Blood 94: suppl.1, abst 505a

  • Beaumont M, Laï JL, Simonnet E, Preudhomme E, Plantier I, Quesnel B, Bauters F, Fenaux P . 2000 Blood 96: 321a

  • Bennett JM, Catowsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C . 1976 Br. J. Haematol. 33: 451–458

  • Bennett JM, Catowsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C . 1980 Ann. Intern. Med. 92: 261–262

  • Bernard J, Weil M, Boiron M, Jacquillat C, Flandrin G, Gemon MF . 1973 Blood 41: 489–496

  • Bernard J, Mathé G, Boulay J . 1959 Schweiz Med. Wochenschr. 89: 604–608

  • Biondi A, Rambaldi A, Pandolfi PP, Rossi V, Giudici G, Alcalay M, Lococo F, Diverio D, Pogliani EM, Lanzi EM . 1992 Blood 80: 492–497

  • Breitman TR, Collins AJ, Keene BR . 1981 Blood 57: 1000–1008

  • Caen J, Larrieu MH, Bernard J . 1959 Rev. Fr. Et. Clin. Biol. 4: 363–366

  • Caen J, Mathé G, Lexman C, Bernard J . 1957 Etude de la fibrinolyse au cours des hémopathies malignes Cong. Eur. Hemat. Karger Eds pp. 502–506

  • Cassinat B, Chomienne C . 2001 Seminars in Hematology. L. Degos (ed) WB Saunders: Philadelphia USA

  • Castaigne S, Balitrand N, de The H, Dejean A, Degos L, Chomienne C . 1992 Blood 79: 3110–3118

  • Castaigne S, Chomienne C, Daniel MT, Ballerini P, Berger R, Fenaux P, Degos L . 1990 Blood 76: 1704–1713

  • Chen ZC, Brand NJ, Chen A, Chen SJ, Tong SH, Wang ZY, Waxman S, Zelent A . 1993 EMBO J. 12: 1161–1167

  • Chomienne C, Balitrand N, Abita JP . 1986 Leuk. Res. 10: 1079–1081

  • Chomienne C, Balitrand N, Cost H, Dagos L, Abita JP . 1986 Leuk. Res. 10: 1301–1305

  • Chomienne C, Ballerini P, Balitrand N, Daniel MT, Fenaux P, Castaigne S, Degos L . 1990 Blood 76: 1710–1719

  • Cornic M, Delva L, Guidez F, Balitrand N, Degos L, Chomienne C . 1992 Cancer Res. 52: 3329–3334

  • Dombret H, Scrobohaci ML, Daniel MT, Miclea JM, Castaigne S, Chomienne C, Fenaux P, Degos L . 1995 Leukemia 9: 19–24

  • Douer D, Preston-Martin S, Chang E, Nichols DW, Watkins KJ, Levine AM . 1996 Blood 87: 308–313

  • Dubois C, Schlageter MH, de Gentile A, Balitrand N, Toubert ME, Krawice I, Fenaux P, Castaigne S, Najean Y, Degos L . 1994 Leukemia 8: 1750–1757

  • Fenaux P, Castaigne S, Dombret H, Archimbaud E, Duarte M, Morel P, Lamy T, Tilly H, Guerci A, Maloisel F . 1992 Blood 80: 2176–2181

  • Fenaux P, Chastang C, Chevret S, Sanz M, Dombret H, Archimbaud E, Fey M, Rayon C, Huguet F, Sotto JJ, Gardin C, Cony-Hakhoul P, Travade P, Solary E, Fegueux N, Bordessoule D, San Miguel J, Link H, Desablens B, Stamatoullas A, Deconinck E, Maloisel F, Castaigne S, Preudhomme C, Degos L . 1999 Blood 94: 1192–1200

  • Fenaux P, Chevret S, Guerci A, Fegueux N, Dombret H, Thomas X, Sanz M, Link H, Maloisel F, Gardin C, Bordessoule D, Stoppa AM, Saddoun A, Muus P, Wandt H, Mineur P, Wittaker JA, Fey M, Daniel MT, Castaigne S, Degos L . 2000 Leukemia 14: 1371–1377

  • Fenaux P, Le Deley MC, Castaigne S, Archimbaud E, Chomienne C, Link H, Duarte M, Daniel MT, Bowero D . 1993 Blood 82: 3241–3249

  • Ferrara F, Morabito F, Martino B, Specchia G, Liso V, Nobile F, Boccuni P, Di Noto R, Pane F, Annunziata M, Schiavone EM, de Simone M, Guglielmi C, Del Vecchio L, Lo Coco F . 2000 J. Clin. Oncol. 18: 1295–1300

  • Frankel SR, Eardley A, Lauwers G, Weiss M, Warrell RP . 1992 Ann. Intern. Med. 117: 293–296

  • Golomb HM, Rowley J, Vardiman J, Baron J, Locker G, Krasnow S . 1976 Arch. Intern. Med. 136: 825–828

  • Guglielmi C, Martelli MP, Diverio D, Feno S, Vegia ML, Cante Rasnoldi M, Biondi A, Cocito MG, Del Vecchio L, Tabilio A, Avvisati G, Basso G, Lo Coco F . 1998 Br. J. Haematol. 102: 1035–1041

  • Hillestad LK . 1957 Acta. Med. Scand. 159: 189–194

  • Huang M, Yu-Chen Y, Shu-Rong C, Chai JR, Lu JX, Zhoa L, Go LJ, Wang ZY . 1988 Blood 72: 567–578

  • Huang W, Sun GL, Li XS, Cao Q, Lu Y, Jang GZ, Zhang FQ, Chai JR, Wang ZY, Waxman S . 1993 Blood 82: 1264–1269

  • Jansen JH, de Ridder MC, Geertsma WM, Eperlink CAJ, Van Lom K, Smit EHE, Slater R, Reigden B, de Greef GE, Sonneveld P, Lowenberg B . 1999 Blood 94: 39–45

  • Kanamaru A, Takemoto Y, Tanimoto M, Murakami H, Asou N, Kobayashi T, Ohmoto E, Sakamaki H, Tsubaki K . 1995 Blood 85: 1202–1206

  • Larson RA, Kondo K, Vardiman JW, Butler AE, Golomb HM, Rowley JD . 1984 Am. J. Med. 76: 827–841

  • Lo Coco F, Diverio D, Avvisati G, Petti MC, Meloni G, Pogliani E, Biondi A, Rossi G, Carlostella C, Selleri C, Martino B, Specchia G, Mandelli F . 1999 Blood 94: 2225–2229

  • Menell JS, Cesarman GM, Jacovina A, McLaughlin MA, Lev EA, Hajjar KA . 1999 N. Engl. J. Med. 340: 994–1004

  • Micléa JM, Chomienne C . 1994 Leukemia 8: 214–215

  • Muindi J, Frankel SR, Miller WH, Jakubowski A, Scheinberg DA, Young CW . 1992 Blood 79: 299–303

  • Murray CK, Estey E, Paietta E, Howard RS, Edenfield WJ, Pierce S, Mann KP, Bolan C, Byrd JC . 1999 J. Clin. Onco. 17: 293–297

  • Redner RL, Rush EA, Faas S, Rudert WA, Corey SJ . 1996 Blood 87: 882–886

  • Rodeghiero F, Avvisati G, Castaman G, Barbui T, Mandellui F . 1990 Blood 75: 2112–2117

  • Rowley JD, Golomb HM, Dougherty C . 1977 Lancet i: 549–550

  • Schoch C, Haase D, Haferlach T, Freund M, Link H, Lengfelder E, Loffler H, Buchner T, Fonatsch C . 1996 Br. J. Haematol. 94: 493–500

  • Slack JL, Arthur DC, Lawrence D, Mrozek K, Mayer RJ, Davey FR, Tantravahi R, Pettanati MJ, Bigner S, Caroll AJ, Rao KW, Schiffer CA, Bloomfield CD . 1997 J. Clin. Oncol. 15: 1786–1795

  • Tallman MS, Andersenn JW, Schiffer CA, Appelbaum FR, Feusner JH, Ogden A, Shepherd L, Willman C, Bloomfield CD, Rowe JM, Wiernik PH . 1997 N. Engl. J. Med. 337: 1021–1028

  • Vahdat L, Maslak P, Miller WH, Eardley A, Heller G, Scheinberg DA, Warrell RP . 1994 Blood 84: 3843–3849

  • Wang ZY, Sun GL, Shen ZX . 1999 Chin. MJ. 112: 963–967

  • Warrell RP, Maslak P, Eardley A, Heller G, Miller WH, Frankel SR . 1994 Leukemia 8: 929–933

  • Warrell RP, Frankel SR, Miller W, Scheinberg DA, Hri LM, Hittelman WN, Vyas R, Andreeff M, Tafuri A, Jakubowski A . 1991 N. Engl. J. Med. 324: 1385–1393

  • Wells RA, Catzavelos C, Kamel-Reid S . 1997 Nat. Genet. 17: 109–113

  • Zhu J, Guo WM, Yao YY, Zhao WL, Pan L, Cai X, Ju B, Sun GL, Wang HL, Chen SJ, Chen GQ, Caen J, Chen Z, Wang ZY . 1999 Leukemia 13: 1062–1070

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Laurent Degos.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Degos, L., Wang, Z. All trans retinoic acid in acute promyelocytic leukemia. Oncogene 20, 7140–7145 (2001). https://doi.org/10.1038/sj.onc.1204763

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1204763

Keywords

  • differentiation
  • promyelocytic leukemia
  • retinoic acid

This article is cited by

Search

Quick links